Matt Silverman focuses on mergers and acquisitions, general corporate matters and securities law. Matt regularly advises publicly traded companies with respect to corporate governance, takeover preparedness and SEC reporting.
Tourmaline Bio Agrees to Merge With Talaris Therapeutics
June 22, 2023
Cooley advised Tourmaline Bio, a late-stage clinical biotechnology company, on its merger agreement with Talaris Therapeutics, including a concurrent private placement.
SoundHound AI Announces $125 Million New Loan Facility From Atlas Credit Partners
April 19, 2023
Cooley advised SoundHound AI, a leader in voice artificial intelligence, in the closing of a new $125 million loan facility from Atlas Credit Partners.
Apollo Endosurgery to Be Acquired by Boston Scientific
February 1, 2023
Cooley advised Apollo Endosurgery, a medical device company, on its agreement to be acquired by Boston Scientific in an all-cash transaction with an enterprise value of approximately $615 million.
CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion
January 10, 2023
Cooley advised CinCor Pharma, a clinical-stage biopharmaceutical company, on its definitive agreement to be acquired by AstraZeneca. M&A partners Rama Padmanabhan and Rowook Park and corporate partners Div Gupta and Sarah Sellers led the Cooley team.
